BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10606092)

  • 1. Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression.
    Smith SM; Holland B; Russo C; Dailey PJ; Marx PA; Connor RI
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1691-701. PubMed ID: 10606092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
    Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive infusion of immune serum into simian immunodeficiency virus-infected rhesus macaques undergoing a rapid disease course has minimal effect on plasma viremia.
    Binley JM; Clas B; Gettie A; Vesanen M; Montefiori DC; Sawyer L; Booth J; Lewis M; Marx PA; Bonhoeffer S; Moore JP
    Virology; 2000 Apr; 270(1):237-49. PubMed ID: 10772996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy.
    Leno M; Carter L; Venzon DJ; Romano J; Markham PD; Limbach K; Tartaglia J; Paoletti E; Benson J; Franchini G; Robert-Guroff M
    AIDS Res Hum Retroviruses; 1999 Mar; 15(5):461-70. PubMed ID: 10195756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Plasma Cell Niche Factors on the Recruitment and Maintenance of IRF4hi Plasma Cells and Plasmablasts in Vaccinated, Simian Immunodeficiency Virus-Infected Rhesus Macaques with Low and High Viremia.
    Shaw JM; Miller-Novak LK; Mohanram V; McKinnon K; Demberg T; Vargas-Inchaustegui DA; Venzon D; Robert-Guroff M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus.
    Smith MO; Heyes MP; Lackner AA
    Lab Invest; 1995 May; 72(5):547-58. PubMed ID: 7745949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques.
    Rybarczyk BJ; Montefiori D; Johnson PR; West A; Johnston RE; Swanstrom R
    J Virol; 2004 Apr; 78(7):3561-71. PubMed ID: 15016879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile.
    Haigwood NL; Watson A; Sutton WF; McClure J; Lewis A; Ranchalis J; Travis B; Voss G; Letvin NL; Hu SL; Hirsch VM; Johnson PR
    Immunol Lett; 1996 Jun; 51(1-2):107-14. PubMed ID: 8811353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route.
    Sodora DL; Lee F; Dailey PJ; Marx PA
    AIDS Res Hum Retroviruses; 1998 Jan; 14(2):171-81. PubMed ID: 9462928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus.
    Chakrabarti L; Baptiste V; Khatissian E; Cumont MC; Aubertin AM; Montagnier L; Hurtrel B
    Virology; 1995 Nov; 213(2):535-48. PubMed ID: 7491778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles.
    Mossman SP; Pierce CC; Watson AJ; Robertson MN; Montefiori DC; Kuller L; Richardson BA; Bradshaw JD; Munn RJ; Hu SL; Greenberg PD; Benveniste RE; Haigwood NL
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):425-34. PubMed ID: 15157361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans.
    Ling B; Veazey RS; Luckay A; Penedo C; Xu K; Lifson JD; Marx PA
    AIDS; 2002 Jul; 16(11):1489-96. PubMed ID: 12131186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-neutralizing Antibodies May Contribute to Suppression of SIVmac239 Viremia in Indian Rhesus Macaques.
    PedreƱo-Lopez N; Rosen BC; Flores WJ; Gorman MJ; Voigt TB; Ricciardi MJ; Crosno K; Weisgrau KL; Parks CL; Lifson JD; Alter G; Rakasz EG; Magnani DM; Martins MA; Watkins DI
    Front Immunol; 2021; 12():657424. PubMed ID: 33796119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
    Tsukamoto T; Yuasa M; Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    J Virol; 2007 Nov; 81(21):11640-9. PubMed ID: 17728225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: transmission efficiency, viral loads, and antibody responses.
    Marthas ML; Lu D; Penedo MC; Hendrickx AG; Miller CJ
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1455-66. PubMed ID: 11679158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breadth and magnitude of antigen-specific antibody responses in the control of plasma viremia in simian immunodeficiency virus infected macaques.
    Pahar B; Kenway-Lynch CS; Marx P; Srivastav SK; LaBranche C; Montefiori DC; Das A
    Virol J; 2016 Dec; 13(1):200. PubMed ID: 27903274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251.
    Villefroy P; Letourneur F; Coutsinos Z; Mortara L; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
    Virol J; 2006 Aug; 3():65. PubMed ID: 16945152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid progressor-specific variant clone of simian immunodeficiency virus replicates efficiently in vivo only in the absence of immune responses.
    Kuwata T; Byrum R; Whitted S; Goeken R; Buckler-White A; Plishka R; Iyengar R; Hirsch VM
    J Virol; 2007 Sep; 81(17):8891-904. PubMed ID: 17596304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.